Pimecrolimus 1% cream for pruritus in postmenopausal diabetic women with vulvar lichen simplex chronicus: A prospective non-controlled case series

Journal of Dermatological Treatment

Volumn 19, Issue 5, 2008, Pages 274-278

  Kelekci, Handan Kiymet ^a   Uncu, Hikmet Gulsen ^b   Yilmaz, Bulent ^b   Ozdemir, Orcun ^b   Sut, Necdet ^c   Kelekci, Sefa ^b  

^a Numune Education and Research Hospital ^*  (Turkey)

^b Numune Education and Research Hospital   (Turkey)

^c TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Lichen simplex chronicus; Pimecrolimus 1 cream; Postmenopausal; Vulvar pruritus

Indexed keywords

PIMECROLIMUS;

ADULT; AGED; APPLICATION SITE BURNING; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; NEURODERMATITIS; PHYSICIAN; POSTMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE; VULVA PRURITUS;

ADULT; AGED; DERMATOLOGIC AGENTS; DIABETES COMPLICATIONS; FEMALE; HUMANS; MIDDLE AGED; NEURODERMATITIS; POSTMENOPAUSE; PROSPECTIVE STUDIES; PRURITUS VULVAE; TACROLIMUS;

EID: 51049105267     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.1080/09546630801955341     Document Type: Article

References (23)

1. MacLean AB, Reid WM. Benign and premalignant disease of the vulva. Br J Obstet Gynaecol. 1995;102:359-63.
2. Kaufman RH, Gardner HL. The clinician-pathologist and vulvar disease. Clin Obstet Gynecol. 1974;17:1-14.
3. Lynch PJ. Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region. Dermatol Ther. 2004;17:8-19.
4. Lynch PJ, Moyal-Barrocco M, Bogliatto F, Micheletti L, Scurry J. 2006 ISSVD classification of vulvar dermatoses: Pathologic subsets and their clinical correlates. J Reprod Med. 2007;52:3-9.
5. Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta-analysis of randomised controlled trials. BMJ. 2005;330:516. Epub 2005 Feb 24.
6. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;1:1-15.
7. Oskay T, Kaya Sezer H, Genc C, Kutluay L. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women. Int J Dermatol. 2007;46:527-32.
8. Sarifakioglu E, Gumus II. Efficacy of topical pimecrolimus in the treatment of chronic vulvar pruritus: A prospective case series - a non-controlled, open-label study. J Dermatolog Treat. 2006;17:276-8.
9. Gisondi P, Ellis CN, Girolomoni G. Pimecrolimus in dermatology: Atopic dermatitis and beyond. Int J Clin Pract. 2005;59:969-74.
10. Li C, Bian D, Chen W, Zhao C, Yin N, Wang Z. Focused ultrasound therapy of vulvar dystrophies: A feasibility study. Obstet Gynecol. 2004;104:915-21.
11. Ayhan A, Guvendag Guven ES, Guven S, Sakinci M, Kucukali T. Medical treatment of vulvar squamous cell hyperplasia. Int J Gynaecol Obstet. 2006;95:278-83.
12. Jonathan S. Berek: Berek and Novak's gynecology. 14th edition. Lippincott Williams & Wilkins, 2007. p. 496.
13. Grassberger M, Steinhoff M, Schneider D, Luger TA. Pimecrolimus - an anti-inflammatory drug targeting the skin. Exp Dermatol. 2004;13:721-30.
14. Graham-Brown RAC, Grassberger M. Pimecrolimus: A review of pre-clinical and clinical data. Int J Clin Pract. 2003;57:319-27.
15. Hoetzenecker W, Meingassner JG, Ecker R, Stingl G, Stuetz A, Elbe-Bürger A. Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. J Invest Dermatol. 2004;122:673-84.
16. Kalthoff FS, Chung J, Musser P, Stuetz A. Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids. Clin Exp Immunol. 2003;133:350-9.
17. Panhans-Gross A, Novak N, Kraft S, Bieber T. Human epidermal Langherans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol. 2001;107:345-52.
18. Gupta AK, Chow M. Pimecrolimus: A review. J Eur Acad Dermatol Venereol. 2003;17:493-503.
19. Goldstein AT, Marinoff SC, Christopher K. Pimecrolimus fort the treatment of vulvar lichen sclerosis: A report of 4 cases. J Reprod Med. 2004;49:778-80.
20. Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol. 2002;46:228-41.
21. Billich A, Aschauer H, Aszódi A, Stuetz A. Percutaneous absorbtion of drugs used in atopic eczema: Pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm. 2004;269:29-35.
22. Boms S, Gambichler T, Freitag M, Altmeyer P, Kreuter A. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood. BMC Dermatol. 2004;4:14.
23. Goldstein AT, Marinoff SC, Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus: A report of 4 cases. J Reprod Med. 2004;49:778-80.